Published in PLoS One on December 22, 2016
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab (2001) 2.98
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) (1994) 2.14
Mutations in the deubiquitinase gene USP8 cause Cushing's disease. Nat Genet (2014) 2.10
Integrated genomic characterization of adrenocortical carcinoma. Nat Genet (2014) 1.81
Dog models of naturally occurring cancer. Trends Mol Med (2011) 1.63
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas. J Clin Invest (2011) 1.49
Medical treatment of Cushing's disease. J Clin Endocrinol Metab (2013) 1.19
Recurrent gain-of-function USP8 mutations in Cushing's disease. Cell Res (2015) 1.17
Results of transsphenoidal hypophysectomy in 52 dogs with pituitary-dependent hyperadrenocorticism. Vet Surg (1998) 0.96
Efficacy of transsphenoidal hypophysectomy in treatment of dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med (2005) 0.96
The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease. J Clin Endocrinol Metab (2015) 0.91
Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol (1997) 0.91
Improved canine exome designs, featuring ncRNAs and increased coverage of protein coding genes. Sci Rep (2015) 0.88
Prognostic factors for outcome after transsphenoidal hypophysectomy in dogs with pituitary-dependent hyperadrenocorticism. J Neurosurg (2007) 0.86
Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane. Clin Tech Small Anim Pract (2007) 0.85
Cushing's disease in dogs and humans. Horm Res (2009) 0.84
Expression of Ki-67, PCNA, and p27kip1 in canine pituitary corticotroph adenomas. Domest Anim Endocrinol (2009) 0.84
The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease. Eur J Endocrinol (2015) 0.83
Hypophysectomy as a treatment for canine and feline Cushing's disease. Vet Clin North Am Small Anim Pract (2001) 0.83
Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential. Horm Metab Res (2012) 0.82
AACE/ACE Disease State Clinical Review: Medical Management of Cushing Disease. Endocr Pract (2014) 0.82
Transsphenoidal hypophysectomy in beagle dogs: evaluation of a microsurgical technique. Vet Surg (1997) 0.81
Pituitary intermediate lobe in dog: two cell types and high bioactive adrenocorticotropin content. Science (1981) 0.80
The pituitary gland: embryology, physiology, and pathophysiology. Neonatal Netw (2000) 0.79
Regulation and secretion of proopiomelanocortin peptides from isolated perifused dog pituitary pars intermedia cells. Endocrinology (1989) 0.79
The New Molecular Landscape of Cushing's Disease. Trends Endocrinol Metab (2015) 0.78
Radiation therapy for pituitary tumors in the dog and cat. Can Vet J (2007) 0.78
Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review. Acta Vet Hung (1998) 0.77
Focal adhesion signaling affects regeneration by human nucleus pulposus cells in collagen- but not carbohydrate-based hydrogels. Acta Biomater (2017) 0.75
Intradiscal application of a PCLA-PEG-PCLA hydrogel loaded with celecoxib for the treatment of back pain in canines: what's in it for humans? J Tissue Eng Regen Med (2017) 0.75